Panacea Acquisition Corp. II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PANA research report →
Price Chart
About the company
Panacea Acquisition Corp. II, which was established in 2021 and is headquartered in San Francisco, California, does not currently conduct substantial business operations. Its central aim is to complete a strategic business combination, such as an acquisition, merger, or reorganization, with one or more enterprises within the biotechnology industry.
- CEO
- Oleg Nodelman
- IPO
- 2021
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on PANA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $10.92
- 52W Low
- $9.69
- 50D MA
- $10.20
- 200D MA
- $9.98
- Beta
- 0.00
- RSI (14)
- 61
- Avg Volume
- 69.48K
No earnings-call transcripts are available for PANA yet.
- Free Float
- 49.5%
- Shares Outstanding
- 23.55M
- Float Shares
- 11.66M
of shares held by institutions
52 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 28, 23 | EcoR1 Panacea Holdings II, LLC | sell | 545,000 |
| Apr 9, 21 | EcoR1 Panacea Holdings II, LLC | buy | 545,000 |
| Apr 6, 20 | EcoR1 Panacea Holdings II, LLC | other | 0 |
| Apr 6, 21 | Platshon Scott | other | 0 |
| Apr 6, 21 | Perlen Scott | other | 0 |
| Apr 6, 21 | Marriott Sarah | other | 0 |
| Apr 6, 21 | Tipirneni Praveen P. | other | 0 |
| Apr 6, 21 | Kjellson Nina S | other | 0 |
| Apr 6, 21 | WILLIAMS DOUGLAS E | other | 0 |
| Apr 6, 21 | Giordano Douglas E. | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PANA coverage
Recent articles, reports, and earnings notes.
No research on PANA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PANA report →Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering
globenewswire.com · Apr 6
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
businesswire.com · Jan 20
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
businesswire.com · Jan 20
Panacea Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing August 21, 2020
businesswire.com · Aug 20
Panacea Acquisition Corp. Announces Pricing of $125,000,000 Initial Public Offering
businesswire.com · Jun 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.